

|

 |
Union Springs Pharmaceuticals develops, licenses, and markets innovative OTC drug and device products for the consumer healthcare market. We are continually evaluating new drugs and devices and their potential value to consumers and professionals.
With the advent of the Internet and mass marketing approaches, there are a large number of products making healthcare claims which fall well short of expectations. Few have real science to support their claims. USP's technologies and products are vigorously tested to meet or exceed all product claims. You can depend on any product manufactured by USP.
Products
MyClyns is the only readily accessible, non-alcohol, first-response spray for healthcare givers and first responders who are exposed to harmful pathogens. MyClyns can be used on the face, in the eyes, mouth, nose and ears. MyClyns contains a topical skin protectant that kills 99.9% of germs in laboratory tests.
Click here to find out more about MyClyns.
Products in Development
Stay tuned...
Business Development
Our main goal in developing business is to establish mutually beneficial alliances that align with USP's corporate vision. We encourage the establishment of collaborative relationships that identify, develop and market innovative technologies.
Union Springs Pharmaceuticals is open to discussions regarding licensing and/or partnership opportunities. Contact us for further information or to initiate a discussion.
|
 |
|